Khattar Jack A. (CIK 1539937) reported 53 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy CGTX (25,000 shares), Buy SUPN (12,500 shares), Sell SUPN (12,500 shares), Sell SUPN (24,138 shares), Sell SUPN (10,742 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | COGNITION THERAPEUTICS INC (CGTX) | Director | Buy | 25,000 | $0 |
| 2026-03-16 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 12,500 | $0 |
| 2026-03-16 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 12,500 | $0 |
| 2026-03-16 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 24,138 | $1.2M |
| 2026-03-16 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 10,742 | $547,842 |
| 2026-03-16 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 120 | $6,210 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 38,640 | $0 |
| 2026-03-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 16,574 | $907,095 |
| 2025-10-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 81,250 | $2.1M |
| 2025-10-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 58,371 | $3.0M |
| 2025-10-10 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 1,529 | $78,682 |
| 2025-10-07 | scPharmaceuticals Inc. (SCPH) | Director | Sell | 5,000 | $0 |
| 2025-10-03 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 20,000 | $0 |
| 2025-10-03 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 7,796 | $360,253 |
| 2025-10-03 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 19,320 | $0 |
| 2025-10-03 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 7,529 | $347,915 |
| 2025-10-03 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 2,267 | $57,355 |
| 2025-10-03 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 1,904 | $91,506 |
| 2025-10-02 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 53,785 | $1.4M |
| 2025-10-02 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 40,173 | $1.9M |
| 2025-10-01 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 11,510 | $291,203 |
| 2025-10-01 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 8,588 | $414,371 |
| 2025-09-30 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 13,688 | $346,306 |
| 2025-09-30 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Sell | 10,235 | $491,485 |
| 2025-09-24 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | President, CEO | Buy | 47,940 | $622,261 |
Source: SEC Form 4 filings · as of 2026-06-22